Literature DB >> 22661269

Involvement of commensal bacteria may lead to dysregulated inflammatory and autoimmune responses in a mouse model for chronic nonsuppurative destructive cholangitis.

Ikuko Haruta1, Ken Kikuchi, Minoru Nakamura, Katsuhiko Hirota, Hidehito Kato, Hiroshi Miyakawa, Noriyuki Shibata, Yoichiro Miyake, Etsuko Hashimoto, Keiko Shiratori, Junji Yagi.   

Abstract

BACKGROUND: We previously reported a mouse model of primary biliary cirrhosis (PBC)-like chronic nonsuppurative destructive cholangitis (CNSDC), in which frequent injections of Streptococcus intermedius induced CNSDC and autoantibody production. The present study was performed to verify the model by examining 1) the reappearance of the PBC-like CNSDC after lymphocyte transfer from model to naïve mice, 2) the involvement of autophagy, and 3) the influence of the strain difference.
METHODS: Mice were inoculated with S. intermedius weekly for 8 weeks, then sacrificed to obtain samples. Spleen cells obtained from S. intermedius-inoculated mice were transferred to RAG2(-/-) mice.
RESULTS: CNSDC and elevated serum level of anti-gp210 titers were observed in S. intermedius-inoculated C57BL/6 mice, similar to the results of our previous report using BALB/c mice. Portal inflammation was induced in the livers of RAG2(-/-) mice by the transfer of spleen cells from S. intermedius-inoculated C57BL/6 mice. Among the inflammatory cells in the RAG2(-/-) mice, CD3-positive cells were predominant. Autophagosome-like structures were detected histologically, in the cytoplasm of infiltrated cells around the bile ducts in the livers of S. intermedius-inoculated both C57BL/6 and BALB/c mice. In S. intermedius-inoculated C3H/HeJ mice, inflammation in the portal area was less extensive than that in the hepatic parenchyma.
CONCLUSION: Bacterial component(s) and sequentially upregulated innate and acquired immune responses, accompanied by autophagy, might trigger CNSDC, via autoimmune mechanisms. Throughout the generation of bacteria-triggered PBC-like CNSDC, strain difference may influence the response to S. intermedius-inoculation in the liver.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22661269     DOI: 10.1007/s10875-012-9712-1

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  54 in total

1.  Immunopathogenesis of primary biliary cirrhosis.

Authors:  Akiyoshi Nishio; Emmet B Keeffe; M Eric Gershwin
Journal:  Semin Liver Dis       Date:  2002-08       Impact factor: 6.115

2.  Environmental factors and the induction of autoimmunity in primary biliary cirrhosis.

Authors:  Carlo Selmi; Alessandro Diana; Claudio A Cocchi; Massimo Zuin; M Eric Gershwin
Journal:  Expert Rev Clin Immunol       Date:  2008-03       Impact factor: 4.473

Review 3.  Genetic and familial considerations of primary biliary cirrhosis.

Authors:  A Tanaka; A T Borchers; H Ishibashi; A A Ansari; C L Keen; M E Gershwin
Journal:  Am J Gastroenterol       Date:  2001-01       Impact factor: 10.864

Review 4.  New insights to the immunopathology and autoimmune responses in primary biliary cirrhosis.

Authors:  Xiao-Song He; Aftab A Ansari; William M Ridgway; Ross L Coppel; M Eric Gershwin
Journal:  Cell Immunol       Date:  2006-01       Impact factor: 4.868

5.  Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic.

Authors:  Dimitrios-Petrou Bogdanos; Harold Baum; Manabu Okamoto; Paolo Montalto; Umesh C Sharma; Eirini I Rigopoulou; John Vlachogiannakos; Yun Ma; Andrew K Burroughs; Diego Vergani
Journal:  Hepatology       Date:  2005-08       Impact factor: 17.425

6.  Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants.

Authors:  Gideon M Hirschfield; Xiangdong Liu; Chun Xu; Yue Lu; Gang Xie; Yan Lu; Xiangjun Gu; Erin J Walker; Kaiyan Jing; Brian D Juran; Andrew L Mason; Robert P Myers; Kevork M Peltekian; Cameron N Ghent; Catalina Coltescu; Elizabeth J Atkinson; E Jenny Heathcote; Konstantinos N Lazaridis; Christopher I Amos; Katherine A Siminovitch
Journal:  N Engl J Med       Date:  2009-05-20       Impact factor: 91.245

Review 7.  Bacteria and human autoimmunity: the case of primary biliary cirrhosis.

Authors:  Carlo Selmi; M Eric Gershwin
Journal:  Curr Opin Rheumatol       Date:  2004-07       Impact factor: 5.006

Review 8.  The causes of primary biliary cirrhosis: Convenient and inconvenient truths.

Authors:  M Eric Gershwin; Ian R Mackay
Journal:  Hepatology       Date:  2008-02       Impact factor: 17.425

9.  Toll-like receptor 4 is a sensor for autophagy associated with innate immunity.

Authors:  Yi Xu; Chinnaswamy Jagannath; Xian-De Liu; Amir Sharafkhaneh; Katarzyna E Kolodziejska; N Tony Eissa
Journal:  Immunity       Date:  2007-07-19       Impact factor: 31.745

10.  Primary biliary cirrhosis following Lactobacillus vaccination for recurrent vaginitis.

Authors:  Dimitrios Bogdanos; Thomas Pusl; Christian Rust; Diego Vergani; Ulrich Beuers
Journal:  J Hepatol       Date:  2008-06-25       Impact factor: 25.083

View more
  5 in total

1.  Escherichia coli infection induces autoimmune cholangitis and anti-mitochondrial antibodies in non-obese diabetic (NOD).B6 (Idd10/Idd18) mice.

Authors:  J J Wang; G-X Yang; W C Zhang; L Lu; K Tsuneyama; M Kronenberg; J L Véla; M Lopez-Hoyos; X-S He; W M Ridgway; P S C Leung; M E Gershwin
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

Review 2.  The intestinal and biliary microbiome in autoimmune liver disease-current evidence and concepts.

Authors:  Timur Liwinski; Melina Heinemann; Christoph Schramm
Journal:  Semin Immunopathol       Date:  2022-05-10       Impact factor: 11.759

3.  Early Prognostic Utility of Gp210 Antibody-Positive Rate in Primary Biliary Cholangitis: A Meta-Analysis.

Authors:  Chunyang Huang; Weijia Han; Chuanmin Wang; Yanmin Liu; Yue Chen; Zhongping Duan
Journal:  Dis Markers       Date:  2019-10-13       Impact factor: 3.434

4.  Ileal mucosa-associated microbiota overgrowth associated with pathogenesis of primary biliary cholangitis.

Authors:  Shogo Kitahata; Yasunori Yamamoto; Osamu Yoshida; Yoshio Tokumoto; Tomoe Kawamura; Shinya Furukawa; Teru Kumagi; Masashi Hirooka; Eiji Takeshita; Masanori Abe; Yoshiou Ikeda; Yoichi Hiasa
Journal:  Sci Rep       Date:  2021-10-05       Impact factor: 4.379

Review 5.  The Pathogenic Factors from Oral Streptococci for Systemic Diseases.

Authors:  Hiromichi Yumoto; Katsuhiko Hirota; Kouji Hirao; Masami Ninomiya; Keiji Murakami; Hideki Fujii; Yoichiro Miyake
Journal:  Int J Mol Sci       Date:  2019-09-15       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.